Top

Published in:

Open Access 01-12-2012 | Case report

Successful treatment of Chlamydophila pneumoniae acute respiratory distress syndrome with extracorporeal membrane oxygenator: a case report and diagnostic review

Authors: David De Bels, Philippe Gottignies, Marijke Reynders, Sébastien Roques, Stephan Wilmin, Véronique-Yvette Miendje Deyi, Sophie Jamart, Jacques Devriendt

Published in: Journal of Medical Case Reports | Issue 1/2012

Abstract

Introduction

Chlamydophila pneumoniae is a respiratory pathogen known to infect the upper and lower respiratory tracts. Infection severity can range from sub-clinical pulmonary infection to acute respiratory distress syndrome.

Case presentation

A previously healthy 62-year-old Caucasian man was admitted to our hospital for acute respiratory failure. Serum samples obtained every week starting from the day of admission showed clear-cut seroconversion for C. pneumoniae antibodies. All other cultures obtained during the first days of hospitalization were negative. Despite maximal ventilatory support (high positive end expiratory pressure, fraction of inspired oxygen of 1.0, nitric oxide inhalation, neuromuscular blocking agents and prone positioning), our patient remained severely hypoxemic, which led us to initiate an extracorporeal membrane oxygenation treatment. Extracorporeal membrane oxygenation and hemodiafiltration were withdrawn on day 12. Our patient was extubated on day 18 and discharged from our Intensive Care Unit on day 20. He went home a month later.

Conclusion

We describe the first published case of acute respiratory distress syndrome due to C. pneumoniae infection successfully treated by extracorporeal membrane oxygenation, a very useful tool in this syndrome. A quick and specific method for the definite diagnosis of Chlamydophila infection should be developed.

Available only for authorised users

Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol. 1998, 187: 23-42. 10.1007/s004300050071.CrossRefPubMed

Elkind MS, Lin IF, Grayston JT, Sacco RL: Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2000, 31: 1521-1525. 10.1161/01.STR.31.7.1521.CrossRefPubMed

Hahn DL, Peeling RW: Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60. Ann Allergy Asthma Immunol. 2008, 101: 614-618. 10.1016/S1081-1206(10)60224-4.CrossRefPubMed

Hoymans VY, Bosmans JM, Ieven MM, Vrints CJ: Chlamydia pneumoniae-based atherosclerosis: a smoking gun. Acta Cardiol. 2007, 62: 565-571. 10.2143/AC.62.6.2024015.CrossRefPubMed

Hunter SF, Hafler DA: Ubiquitous pathogens: links between infection and autoimmunity in MS?. Neurology. 2000, 55: 164-165.CrossRefPubMed

Lieberman D, Ben-Yaakov M, Lazarovich Z, Porath A, Schlaeffer F, Leinonen M, Saikku P, Horovitz O, Boldur I: Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection. 1996, 24: 109-114. 10.1007/BF01713313.CrossRefPubMed

Liu KT, Yang KY, Lee YC, Perng RP: Risk factor analysis of acute respiratory distress syndrome among hospitalized patients with Chlamydophila pneumoniae pneumonia. J Chin Med Assoc. 2007, 70: 318-323. 10.1016/S1726-4901(08)70012-1.CrossRefPubMed

Gnarpe J, Gnarpe H, Nissen K, Haldar K, Naas J: Chlamydia pneumoniae infection associated with multi-organ failure and fatal outcome in a previously healthy patient. Scand J Infect Dis. 1998, 30: 523-524. 10.1080/00365549850161584.CrossRefPubMed

File TM, Plouffe JF, Breiman RF, Skelton SK: Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia. Clin Infect Dis. 1999, 29: 246-248.

10.

Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, Matsushima T: Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest. 2002, 121: 1776-1781. 10.1378/chest.121.6.1776.CrossRefPubMed

11.

Patroniti N, Zangrillo A, Pappalardo F, Peris A, Cianchi G, Braschi A, Iotti GA, Arcadipane A, Panarello G, Ranieri VM, Terragni P, Antonelli M, Gattinoni L, Oleari F, Pesenti A: The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med. 2011, 37: 1447-1457. 10.1007/s00134-011-2301-6.CrossRefPubMed

12.

Patroniti N, Bellani G, Pesenti A: Nonconventional support of respiration. Curr Opin Crit Care. 2011, 17: 527-532. 10.1097/MCC.0b013e32834a4be7.CrossRefPubMed

13.

Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, CESAR trial collaboration: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009, 374: 1351-1363. 10.1016/S0140-6736(09)61069-2.CrossRefPubMed

14.

Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, Forrest P, Gattas D, Granger E, Herkes R, Jackson A, McGuinness S, Nair P, Pellegrino V, Pettilä V, Plunkett B, Pye R, Torzillo P, Webb S, Wilson M, Ziegenfuss M: Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009, 302: 1888-1895.CrossRef

15.

Lynch JE, Hayes D, Zwischenberger JB: Extracorporeal CO(2) removal in ARDS. Crit Care Clin. 2011, 27: 609-625. 10.1016/j.ccc.2011.05.002.CrossRefPubMed

16.

Florchinger B, Philipp A, Klose A, Hilker M, Kobuch R, Rupprecht L, Keyser A, Puhler T, Hirt S, Wiebe K, Müller T, Langgartner J, Lehle K, Schmid C: Pumpless extracorporeal lung assist: a 10-year institutional experience. Ann Thorac Surg. 2008, 86: 410-417. 10.1016/j.athoracsur.2008.04.045. discussion 417CrossRefPubMed

17.

Liebold A, Philipp A, Kaiser M, Merk J, Schmid FX, Birnbaum DE: Pumpless extracorporeal lung assist using an arterio-venous shunt. Applications and limitations. Minerva Anestesiol. 2002, 68: 387-391.PubMed

18.

Walles T: Clinical experience with the iLA Membrane Ventilator pumpless extracorporeal lung-assist device. Expert Rev Med Devices. 2007, 4: 297-305. 10.1586/17434440.4.3.297.CrossRefPubMed

19.

Grayston JT, Diwan VK, Cooney M, Wang SP: Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med. 1989, 149: 169-173. 10.1001/archinte.1989.00390010145020.CrossRefPubMed

20.

Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988, 2: 983-986.CrossRefPubMed

21.

Kalayoglu MV, Libby P, Byrne GI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002, 288: 2724-2731. 10.1001/jama.288.21.2724.CrossRefPubMed

22.

Hammerschlag MR: Chlamydia pneumoniae and the lung. Eur Respir J. 2000, 16: 1001-1007. 10.1183/09031936.00.16510010.CrossRefPubMed

23.

Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR, C. pneumoniae Workshop Participants: Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 2001, 33: 492-503. 10.1086/322632.CrossRefPubMed

24.

Loens K, Goossens H, Ieven M: Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis. 2010, 29: 1055-1069. 10.1007/s10096-010-0975-2.CrossRefPubMed

25.

Kumar S, Hammerschlag MR: Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis. 2007, 44: 568-576. 10.1086/511076.CrossRefPubMed

26.

Persson K, Haidl S: Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci. APMIS. 2000, 108: 131-138. 10.1034/j.1600-0463.2000.d01-36.x.CrossRefPubMed

Title: Successful treatment of Chlamydophila pneumoniae acute respiratory distress syndrome with extracorporeal membrane oxygenator: a case report and diagnostic review
Authors: David De Bels
Philippe Gottignies
Marijke Reynders
Sébastien Roques
Stephan Wilmin
Véronique-Yvette Miendje Deyi
Sophie Jamart
Jacques Devriendt
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Journal of Medical Case Reports / Issue 1/2012
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/1752-1947-6-20

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Successful treatment of Chlamydophila pneumoniae acute respiratory distress syndrome with extracorporeal membrane oxygenator: a case report and diagnostic review

Abstract

Introduction

Case presentation

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2012

Distended bladder presenting with constipation and venous obstruction: a case report

Subcutaneous metastases from colon cancer: a case report

Intravesical colistin irrigation to treat multidrug-resistant Acinetobacter baumannii urinary tract infection: a case report

Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report

A clinical analysis of nine new pediatric and adolescent cases of benign minor salivary gland neoplasms and a review of the literature

Endoscopic hemostasis with endoscopic mucosal resection and multiple synchronous early gastric cancers: a case report